Procter & Gamble (NYSE:PG - Get Free Report) had its target price dropped by analysts at UBS Group from $186.00 to $180.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. UBS Group's price target would suggest a potential upside of 16.78% from the company's previous close.
A number of other research firms have also recently commented on PG. Erste Group Bank cut Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Citigroup decreased their price target on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. JPMorgan Chase & Co. cut their price objective on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating for the company in a report on Friday, April 11th. Barclays boosted their price objective on Procter & Gamble from $160.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday. Finally, Royal Bank Of Canada raised Procter & Gamble from a "sector perform" rating to an "outperform" rating and upped their target price for the stock from $164.00 to $177.00 in a research note on Friday, April 25th. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $176.80.
View Our Latest Stock Report on PG
Procter & Gamble Price Performance
NYSE PG traded up $0.40 during trading on Thursday, hitting $154.13. 1,842,680 shares of the company's stock were exchanged, compared to its average volume of 7,622,962. The company has a current ratio of 0.71, a quick ratio of 0.50 and a debt-to-equity ratio of 0.47. The company has a market cap of $361.37 billion, a PE ratio of 24.47, a P/E/G ratio of 4.35 and a beta of 0.40. Procter & Gamble has a fifty-two week low of $151.90 and a fifty-two week high of $180.43. The stock's 50 day moving average price is $161.43 and its two-hundred day moving average price is $164.61.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. The business had revenue of $19.78 billion for the quarter, compared to analysts' expectations of $20.42 billion. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The firm's revenue was down 2.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.52 earnings per share. Research analysts expect that Procter & Gamble will post 6.91 EPS for the current year.
Insider Activity
In other Procter & Gamble news, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the sale, the chief executive officer owned 51,965 shares of the company's stock, valued at $8,386,111.70. The trade was a 1.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the business's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the transaction, the insider directly owned 25,182 shares in the company, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by company insiders.
Institutional Investors Weigh In On Procter & Gamble
Hedge funds have recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC increased its position in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after buying an additional 76,017,350 shares in the last quarter. Norges Bank acquired a new position in Procter & Gamble during the 4th quarter valued at about $5,244,463,000. Nuveen LLC acquired a new position in Procter & Gamble during the 1st quarter valued at about $1,954,941,000. GAMMA Investing LLC increased its holdings in shares of Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after purchasing an additional 7,913,335 shares during the period. Finally, Capital Research Global Investors increased its holdings in shares of Procter & Gamble by 62.5% in the fourth quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock valued at $1,240,294,000 after purchasing an additional 2,846,560 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Company Profile
(
Get Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.